Precision Drilling
PDS
Lantheus
LNTH
eBay
EBAY
4
DexCom
DXCM
5
Collegium Pharmaceutical
COLL
US Stock MarketDetailed Quotes
AUTL Autolus Therapeutics
- 1.550
- -0.110-6.63%
Close Mar 31 16:00 ET
- 1.590
- +0.040+2.58%
Post 19:32 ET
412.50MMarket Cap-1.80P/E (TTM)
1.630High1.520Low2.19MVolume1.610Open1.660Pre Close3.41MTurnover1.60%Turnover RatioLossP/E (Static)266.13MShares5.67052wk High0.97P/B213.04MFloat Cap1.52052wk Low--Dividend TTM137.45MShs Float53.240Historical High--Div YieldTTM6.63%Amplitude1.520Historical Low1.556Avg Price1Lot Size
About Autolus Therapeutics Company
Autolus Therapeutics Plc is a biopharmaceutical company, which engages in the development and commercialization of gene therapies. It uses proprietary and modular T cell programming technologies that are designed to recognize cancer cells, break down their defense mechanisms, and attack and kill these cells. The company was founded by Martin Pule in September 2014 and is headquartered in London, the United Kingdom.
Company Profile
SymbolAUTL
Company NameAutolus Therapeutics
Listing DateJun 22, 2018
Issue Price17.00
Founded2018
CEODr. Christian Itin, PhD.
MarketNASDAQ
Employees647
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
AddressThe Mediaworks,191 Wood Lane,White City
CityLondon
ProvinceGreater London
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeW12 7FP
Phone44-20-3829-6230
Websitehttp://www.autolus.com
Company Executives
- Name
- Position
- Salary
- Dr. Christian Itin, PhD.
- Chief Executive Officer and Director
- 1.93M
- Miranda Neville
- Senior Vice President and Chief Project Officer
- --
- Robert F. Dolski
- Senior Vice President and Chief Financial Officer
- --
- Martin Pule, M.B.B.S.
- Senior Vice President and Chief Scientific Officer
- --
- David Brochu
- Senior Vice President and Chief Technical Officer
- --
- Christopher Vann
- Senior Vice President and Chief Operating Officer
- --
- Brent Rice
- Senior Vice President and Chief Commercial Officer
- --
- Alexander Swan
- Senior Vice President and Chief Human Resources Officer
- --
- Dr. Matthias Will, M.D.
- Senior Vice President and Chief Development Officer
- --
- Dr. Christopher Willia PhD
- Senior Vice President and Chief Business Development Officer
- --
- Andrew Mercieca
- Vice President, Finance and Principal Accounting Officer
- --
- Alex Driggs
- Senior Vice President, Legal Affairs and General Counsel
- --
- Michael W. Bonney
- Chairman of the Board
- 389.12K
- Linda C. Bain
- Independent Director
- 196.20K
- Cynthia M. Butitta
- Independent Director
- 190.82K
- William D. Young, PhD
- Independent Director
- 196.66K
- Robert W. Azelby
- Independent Director
- 371.16K
- John E. Berriman
- Independent Director
- 189.32K
- Dr. Robert Iannone, M.D.
- Independent Director
- 193.94K
- Dr. Ravi Madduri Rao, M.D.
- Independent Director
- 302.73K
- Dr. Martin Patrick Murphy, PhD
- Independent Director
- 184.33K
- Dr. Joseph Anderson, PhD.
- Independent Director
- 189.70K
- Dr. Elisabeth Leiderman, M.D.
- Independent Director
- 326.45K
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call